samedan logo
 
 
 
spacer
home > pmps > autumn 2018 > encounters in transportation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Encounters in Transportation

Supply chain logistics experts understand that the transportation of any type of goods comes with their own set of challenges. When cold chain logistics are taken into account, a new set of unique obstacles are introduced.

To start, the cold chain market is growing. According to Qy Research Groups’ Global Cold Chain Logistics Market Size, Status and Forecast 2022 report, the global cold chain market is expected to reach US $426.2 billion by 2022. Pharmaceutical Commerce reported that cold chain logistics spending is forecast to grow to more than US $16 billion by 2020. Data points back to the rising demand for pharmaceuticals as one of the main factors driving demand for the temperature-controlled supply chain. This demand also stems from an aging population, which, in turn, is starting to require more medication, which must stay at specified temperatures.

By 2050, 16% of the world’s population will be 65 or older. Baby Boomers started turning 65 in 2011, and the American Hospital Association projects that by 2030, more than 60% of this generation will be managing more than one chronic condition. Additionally, Milliman reports that increased life expectancies will trigger greater consumption patterns in the population for medical services and pharmaceuticals.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Angela Kerr is Vice President of product portfolio at SpotSee. In this role, Angela focusses on building the company’s existing business and developing the next generation of cloud-based products that help customers costeffectively track their products around the globe. She has a Bachelor of Science degree in electrical engineering from Texas Tech University, US.
spacer
Angela Kerr
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

bioMérieux announces the expansion of the CE marking of its molecular biology ARGENE® SARS-CoV-2 diagnostic test to include saliva specimens.

Marcy l’Etoile, France – November 16, 2020 – bioMérieux, a world leader in the field of in vitro diagnostics, has announced the expansion of its ARGENE® range for the detection of SARS-CoV-2. As a complement to nasopharyngeal swab specimens, the singleplex SARS-CoV-2 R-GENE® real-time PCR test may now be used on saliva and oropharyngeal (throat) swab specimens for the detection of the virus that causes COVID-19. This development helps optimize laboratory workflows.
More info >>

White Papers

Accelerate Your Database Lock Using Clean Patient Optics

Bioclinica

Because a key step towards database lock is obtaining clean data for all patients, the ability to verify that data are clean early accelerates the ability to lock the clinical database. This ultimately shortens the overall study timeline while ensuring the quality of your data. However, this can be challenging when manually reviewing study data, particularly with larger studies.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement